H. : Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J. Pharmacol. Exp. Ther. 187 , 365–371 (1973).Yang HY, Neff NH (1973) Beta-phenylethylamine: a specific substrate for type b monoamine oxidase of brain. J Pharmacol Exp Ther 187(2):365–371...
Beta-Phenylethylamine and Synephrine Hydrochloride 青云英语翻译 请在下面的文本框内输入文字,然后点击开始翻译按钮进行翻译,如果您看不到结果,请重新翻译! 翻译结果1翻译结果2翻译结果3翻译结果4翻译结果5 翻译结果1复制译文编辑译文朗读译文返回顶部 β-苯乙胺和辛弗林盐酸盐...
待解决 悬赏分:1 - 离问题结束还有 beta phenylethylamine HCL问题补充:匿名 2013-05-23 12:21:38 公测苯乙胺HCL 匿名 2013-05-23 12:23:18 苯基乙胺测试硬件兼容性列表(HCL) 匿名 2013-05-23 12:24:58 beta苯乙胺HCL 匿名 2013-05-23 12:26:38 beta 苯乙胺盐酸盐 匿名 2013-05-23 1...
Methylene-beta-phenylethylimine formation from 5-methyltetrahydrofolic acid and beta-phenylethylamine.Hsu LL, Mandell AJ.doi:10.1016/0024-3205(75)90488-9Hsu, L LMandell, A JLife SciencesHsu, L. L., and Mandell, A. J., 1975, Methylene- β -phenylethylimine formation from 5-methyl...
The 5-hydroxytryptamine (5HT) receptor blocker, methysergide (10 mg/kg), was found to potentiate the behavioural effects of β-phenylethylamine (PEA) (at doses between 20 and 60 mg/kg) on food reinforced schedule-maintained behaviour in two separate experiments involving a fixed interval 2 min...
A gas chromatographic procedure is described for the analysis of beta-phenylethylamine (PEA) in tissues and body fluids. The method involves the use of pentafluorobenzenesulfonyl chloride for extraction and derivatization of PEA. This is followed by separation and analysis of the derivatized amine on...
如以前说,洋槐 rigidula 抑制胃口。一旦身体不再拥有增碳器,开始使用脂肪。N 木精-phenylethylamine, methylsynephrine, theobromine 在加速故障脂肪,导致体重减少。Beta-adrenergic 系统为了 lipolysis 使其变得更容易的举行。 翻译结果3复制译文编辑译文朗读译文返回顶部 ...
あらゆる種類の家畜飼育のために、Alibaba.comから美味しくて栄養価の高いβ フェニルエチルアミンhcl粉末を入手してください。これらの優れたβ フェニルエチルアミンhcl粉末は、家畜の健康と食物を向上させます。
Beta-phenylethylamine (PE) (75 mg/kg once daily) was administered to mice for 1, 4 or 9 days, and behavioural and biochemical experiments performed 1 day after the last treatment dose. There was no quantitative change in sensitivity of PE treated mice to the post synaptic dopamine (DA) ...
The present invention provides a therapeutic composition comprising a synergistic combination of caffeine, ginkgo biloba , and 尾-phenylethylamine (PEA) or its salt. The invention is also directed to oral dosage forms containing said composition, and to a method of treatment of a psychological, ...